Adjuvant Folfox4 with or without Cetuximab (CTX) in Patients (PTS) with Resected Stage III Colon Cancer (CC): Dfs and OS Results and Subgroup Analyses of the PETACC8 Intergroup Phase III Trial

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 23; p. ixe9
Main Authors Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J., Thaler, J., Bridgewater, J.A., Van Cutsem, E.J.D., Rougier, P., Collette, L., Praet, M., Schneider, M., Bouché, O., Lepage, C., Girault, C., Emile, J.F., Laurent-Puig, P., Bedenne, L.
Format Journal Article
LanguageEnglish
Published 01.09.2012
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/S0923-7534(20)34317-9